Codexis Expands and Strengthens its Leadership Team with Two Executive Hires
“We are fortunate to welcome two extraordinary professionals to lead functions that are critical to future growth in both our Performance Enzymes and our Novel Biotherapeutics business segments,” stated
“Stefan brings unprecedented knowledge in protein engineering and synthetic biology, which are at the core of our R&D activities. He and his accomplishments are well-known and highly regarded within our industry and by many of our scientists at
“Karl has proven success in leading dynamic, multi-functional teams and growing numerous global specialty chemical platform businesses in a wide variety of settings over his substantial career,” said
To the extent that statements contained in this press release are not descriptions of historical facts regarding
LHA Investor Relations
Photos accompanying this announcement are available at
Source: Codexis, Inc.